Serum Institute of India

South Africa's order of 1.4 million doses of COVID-19 vaccines from Serum Institute of India has been cancelled citing export ban by the Indian government. Reportedly, the South African government, which was sure enough to complete the vaccine order, has been facing severe pressure from the opposition over failure to deal with pharma companies. Moreover, its collaboration with global initiative ‘Covax' will only provide 10% shots for its… read-more

Reacting to emergency approval of COVID-19 vaccines, Congress MP Shashi Tharoor said the premature authorization of ‘Covaxin’ may be unsafe as it is still undergoing the Phase-3 clinical trials.  Moreover, he requested Health Minister Harsh Vardhan to wait for the final stage of Covaxin, meanwhile resort to the AstraZeneca vaccine. Earlier, Indian Drug Controller General had announced emergency and restricted use of COVID vaccines from Serum… read-more

The Serum Institute of India has successfully developed the country's first indigenous vaccine against pneumonia. The domestic vaccine will reduce the dependency on earlier two vaccines by Pfizer and GlaxoSmithKline, both foreign drug-makers. After securing approval by the Indian drug regulator in July 2020, the SII has conducted the vaccine's trials in India and the Gambia of Africa. Reportedly, the vaccine will be available in the Indian… read-more

The Serum Institute of India (SII) on December 6 has applied for emergency-use authorisation for its COVID-19 vaccine, 'Covishield'. By approaching the Drugs Controller General of India  (DCGI), the SII is the first domestic firm to seek approval. 'Covishield' is being jointly developed by the SII, ICMR and Oxford University. US-based Pfizer has also sought the same approval for its COVID-19 vaccine. Pfizer has already secured approval from… read-more

Indian government is planning to grant approval to Serum Institute of India (SII) for emergency use of Oxford-AstraZeneca COVID-19 vaccine. With this, the country can get its first vaccination drill by late January-early February. However, the formal application from the SII will be submitted in December once the vaccine gets approval from the UK. The government is also eyeing to procure the vaccine at 50% discount, meaning Rs 500-600 for two… read-more